MSD's Gardasil®9, a nine-valent HPV vaccine, is approved for use in males between 16 and 26 years old by China's National Medical Products Administration on Monday. [Photo provided to chinadaily ...

United States-based global pharmaceutical company MSD said on Monday that China's National Medical Products Administration has approved the use of multiple new indications of Gardasil®9, its ...

Kennedy Jr., experts looked poised to change policies around vaccines that defend against two of the world’s most high-profile viruses—COVID and HPV. Following Tuesday's deliberations ...

MRK’s leading HPV vaccine, GARDASIL 9, faced challenges internationally due to inventory buildup within its Chinese distributor, which is expected to reduce shipments for the remainder of 2024.

This vaccine showed 100% protection in mice studies against a lethal H5N1 bird flu strain. This week the results were published in a peer-reviewed scientific journal. RELATED: More bird flu ...

Lagevrio (molnupiravir) added $3.2 billion to Merck's top line of $15.9 billion ... Keytruda (pembrolizumab) and the Gardasil human papillomavirus (HPV) vaccine range. The strong performance ...

Safety documentation is a priority in all phases of the vaccine clinical trials. Safety is categorized as local reactions from the injection itself and as systemic reactions that may occur ...

This alliance merges SMX's invisible molecular marking and blockchain-based platform with Aegis Packaging's O₂X™ coating technology offering a seamless way to enhance the recyclability and ...

THURSDAY, April 17, 2025 (HealthDay News) — A panel of federal health experts on Wednesday recommended expanded vaccine options for several diseases, including respiratory syncytial virus (RSV ...